Clindamycin phosphate 1·2%–benzoyl peroxide 3·0% fixed‐dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase 3, multicentre, randomized, single‐blinded, active‐controlled, parallel group study

ConclusionsCompared with CLNP twice daily, CLNP/BPO 3·0% once daily was more effective and CLNP/BPO 3·0% twice daily at least as effective, with an early onset of action and an acceptable safety and tolerability profile in Japanese patients.

Source: British Journal of Dermatology - January 7, 2015 Category: Dermatology Authors: M. Kawashima, H. Hashimoto, A.B. Alió Sáenz, M. Ono, M. Yamada Tags: Therapeutics Source Type: research